Fanny Cavalie - Feb 14, 2022 Form 3/A - Amendment Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Strategy/Bus Ops Officer
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Feb 14, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
9/9/2022, 07:38 PM
Date Of Original Report
Feb 24, 2022
Next filing
Jan 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FHTX Stock Options (Right to buy) Feb 14, 2022 Common Stock 125K $14.87 Direct F1
holding FHTX Stock Options (Right to buy) Feb 14, 2022 Common Stock 50K $16.63 Direct F2
holding FHTX Stock Options (Right to buy) Feb 14, 2022 Common Stock 59.5K $8.77 Direct F3
holding FHTX Stock Options (Right to buy) Feb 14, 2022 Common Stock 10.1K $3.72 Direct F4
holding FHTX Stock Options (Right to buy) Feb 14, 2022 Common Stock 5.58K $0.73 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 26, 2023, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F2 The option vests as to 25% of the underlying shares of common stock on January 28, 2022, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F3 The option vests as to 25% of the underlying shares of common stock on August 17, 2021, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F4 The option vests as to 25% of the underlying shares of common stock on January 30, 2020, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F5 The option vests as to 25% of the underlying shares of common stock on March 19, 2019, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.

Remarks:

Due to an administrative error, the vesting schedule of each of the awards set forth in Table II was incorrectly described in the original Form 3 filed on February 24, 2022. This Form 3/A includes the corrected vesting schedule for each such award. This Form 3/A is also being filed to include the Reporting Person's Power of Attorney as Exhibit 24.